Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan

Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart fai...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2015
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24997
Acceso en línea:
https://doi.org/10.14740/jocmr2323w
https://repository.urosario.edu.co/handle/10336/24997
Palabra clave:
Cardiorespiratory Medicine and Haematology
Medical and Health Sciences
Rights
License
Abierto (Texto Completo)
id EDOCUR2_0376c7938aa0c62849c0e3790e72e78b
oai_identifier_str oai:repository.urosario.edu.co:10336/24997
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling d0cbbaa9-ff7b-484a-bb2c-9f25ddb8c870-1fedddac8-704b-4df3-a1c4-1e4b3101fd2b-187e3a6f3-f1ee-40c4-89ec-89cedd5e5bec-12b480db8-d121-43c7-acfb-f23d859c210d-135ec42c5-4d19-4d0c-a9c6-ed85995ff317-199b40276-a33d-401e-a27a-417285acf4e2-12020-06-11T13:22:02Z2020-06-11T13:22:02Z2015Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart failure. Transthoracic echocardiography showed severe mitral insufficiency, mild left ventricular dysfunction, mild tricuspid insufficiency, severe pulmonary hypertension, and right atrial enlargement. With wet and cold heart failure signs, the patient was a candidate for inodilator cardiovascular support and volume depletion therapy. As the patient presented a persistent tachycardia at rest, levosimendan was chosen over dobutamine. Levosimendan was administered at a dose of 0.2 g/kg/min during a period of 24 hours. After inodilator therapy, the patient's signs and symptoms of heart failure began to decrease, showing improvement of dyspnea, mitral murmur grade went from IV/IV to II/IV, filling pressures and systemic and pulmonary resistance indexes decreased, arterial blood gases improved, and an echocardiography performed 72 h later showed non-dilated cardiomyopathy, mild cardiac contractile dysfunction, mild mitral insufficiency, type I diastolic dysfunction and improvement of pulmonary hypertension. Cardiovascular function in peripartum cardiomyopathy tends to go back to normality in 23-41% of the cases, but in a large group of patients, severe ventricle dysfunction remains months after initial symptoms. This article describes the diagnostic process of a patient with peripartum cardiomyopathy and a successful reversion of a severe case of mitral insufficiency using levosimendan as a new therapeutic strategy in this clinical context.application/pdfhttps://doi.org/10.14740/jocmr2323whttps://repository.urosario.edu.co/handle/10336/24997engJournal of Clinical Medicine Research1001No. 12998Journal of Clinical Medicine ResearchVol. 7Journal of Clinical Medicine Research, ISSN: , Vol.7, No.12 (2015); pp. 998-1001https://www.jocmr.org/index.php/JOCMR/article/download/2323/1314Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCardiorespiratory Medicine and HaematologyMedical and Health SciencesReversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using LevosimendanarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Estrada, Victor H. NietoFranco, Daniel L. MolanoMoreno, Albert Alexander ValenciaGambasica, Jose A. RojasBornacelli, Yamil E. JallerDel Valle, Anacaona MartinezORIGINAL2323-12474-1-PB.pdfapplication/pdf1281755https://repository.urosario.edu.co/bitstreams/53c9ea9c-10b1-4392-903a-a169d90a1a94/download5740a8c76ed8219a2636acdfe8ab940eMD51TEXT2323-12474-1-PB.pdf.txt2323-12474-1-PB.pdf.txtExtracted texttext/plain19172https://repository.urosario.edu.co/bitstreams/119d73d4-e005-4b9e-9a9c-1434b336e806/downloaddf31166dc3a0f1fc6cf7c0d368361897MD52THUMBNAIL2323-12474-1-PB.pdf.jpg2323-12474-1-PB.pdf.jpgGenerated Thumbnailimage/jpeg4289https://repository.urosario.edu.co/bitstreams/a79d75bc-e15b-4078-8090-b1cfb0bbb21e/downloadc4e1b52eed187284f851fdcb9d96b2dfMD5310336/24997oai:repository.urosario.edu.co:10336/249972021-06-03 00:50:51.85https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
title Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
spellingShingle Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
Cardiorespiratory Medicine and Haematology
Medical and Health Sciences
title_short Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
title_full Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
title_fullStr Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
title_full_unstemmed Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
title_sort Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
dc.subject.keyword.spa.fl_str_mv Cardiorespiratory Medicine and Haematology
Medical and Health Sciences
topic Cardiorespiratory Medicine and Haematology
Medical and Health Sciences
description Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart failure. Transthoracic echocardiography showed severe mitral insufficiency, mild left ventricular dysfunction, mild tricuspid insufficiency, severe pulmonary hypertension, and right atrial enlargement. With wet and cold heart failure signs, the patient was a candidate for inodilator cardiovascular support and volume depletion therapy. As the patient presented a persistent tachycardia at rest, levosimendan was chosen over dobutamine. Levosimendan was administered at a dose of 0.2 g/kg/min during a period of 24 hours. After inodilator therapy, the patient's signs and symptoms of heart failure began to decrease, showing improvement of dyspnea, mitral murmur grade went from IV/IV to II/IV, filling pressures and systemic and pulmonary resistance indexes decreased, arterial blood gases improved, and an echocardiography performed 72 h later showed non-dilated cardiomyopathy, mild cardiac contractile dysfunction, mild mitral insufficiency, type I diastolic dysfunction and improvement of pulmonary hypertension. Cardiovascular function in peripartum cardiomyopathy tends to go back to normality in 23-41% of the cases, but in a large group of patients, severe ventricle dysfunction remains months after initial symptoms. This article describes the diagnostic process of a patient with peripartum cardiomyopathy and a successful reversion of a severe case of mitral insufficiency using levosimendan as a new therapeutic strategy in this clinical context.
publishDate 2015
dc.date.created.spa.fl_str_mv 2015
dc.date.accessioned.none.fl_str_mv 2020-06-11T13:22:02Z
dc.date.available.none.fl_str_mv 2020-06-11T13:22:02Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.14740/jocmr2323w
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24997
url https://doi.org/10.14740/jocmr2323w
https://repository.urosario.edu.co/handle/10336/24997
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1001
dc.relation.citationIssue.none.fl_str_mv No. 12
dc.relation.citationStartPage.none.fl_str_mv 998
dc.relation.citationTitle.none.fl_str_mv Journal of Clinical Medicine Research
dc.relation.citationVolume.none.fl_str_mv Vol. 7
dc.relation.ispartof.spa.fl_str_mv Journal of Clinical Medicine Research, ISSN: , Vol.7, No.12 (2015); pp. 998-1001
dc.relation.uri.spa.fl_str_mv https://www.jocmr.org/index.php/JOCMR/article/download/2323/1314
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Journal of Clinical Medicine Research
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/53c9ea9c-10b1-4392-903a-a169d90a1a94/download
https://repository.urosario.edu.co/bitstreams/119d73d4-e005-4b9e-9a9c-1434b336e806/download
https://repository.urosario.edu.co/bitstreams/a79d75bc-e15b-4078-8090-b1cfb0bbb21e/download
bitstream.checksum.fl_str_mv 5740a8c76ed8219a2636acdfe8ab940e
df31166dc3a0f1fc6cf7c0d368361897
c4e1b52eed187284f851fdcb9d96b2df
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167504637919232